Crizotinib 250mg Capsule (LuciCriz) Price in Pakistan | Impo Medic
₨ 0
Description
Crizotinib 250mg Capsule (LuciCriz) Price in Pakistan
Crizotinib 250mg Capsule (LuciCriz) contains crizotinib, a targeted anticancer medicine classified as a kinase inhibitor. It is used for the treatment of selected patients with metastatic non-small cell lung cancer (NSCLC) whose tumours test positive for specific genetic alterations, particularly ALK or ROS1.
LuciCriz 250mg is manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd. It provides targeted treatment by blocking abnormal signalling pathways involved in cancer-cell growth and survival.
Uses of Crizotinib 250mg
Crizotinib may be prescribed for eligible patients with:
- ALK-Positive NSCLC: Metastatic non-small cell lung cancer with an anaplastic lymphoma kinase (ALK) genetic alteration.
- ROS1-Positive NSCLC: Metastatic non-small cell lung cancer with a ROS1 genetic alteration.
- Targeted Lung Cancer Treatment: An option for patients whose tumour molecular testing confirms a suitable genetic target.
Treatment eligibility should be established through appropriate molecular testing before starting therapy.
How Crizotinib Works
Crizotinib blocks specific receptor tyrosine kinases, including anaplastic lymphoma kinase (ALK), ROS1 and MET. These proteins can become abnormally active in certain cancer cells and promote uncontrolled growth.
By inhibiting these signalling pathways, crizotinib helps slow cancer-cell multiplication and tumour progression in patients with relevant molecular alterations.
Dosage and Administration
For adults with ALK-positive or ROS1-positive metastatic NSCLC, the commonly recommended dosage in prescribing information is 250mg twice daily.
- Take the capsule orally according to the oncologist’s instructions.
- It may be taken with or without food.
- Swallow capsules whole with water.
- Do not crush, chew or open the capsules.
- Treatment generally continues until disease progression or unacceptable toxicity, as determined by the treating oncologist.
Dosage adjustments may be necessary depending on kidney or liver function, treatment tolerance and drug interactions. Do not change or discontinue treatment without medical advice.
Precautions
- Confirm ALK or ROS1 tumour status using an appropriate validated diagnostic test.
- Liver function should be monitored because crizotinib can cause serious hepatotoxicity.
- Report new or worsening cough, breathing difficulty or chest discomfort because interstitial lung disease and pneumonitis can occur.
- Crizotinib may affect heart rhythm by prolonging the QT interval; ECG and electrolyte monitoring may be necessary.
- It can slow the heart rate, so heart rate and blood pressure monitoring may be required.
- Inform your doctor about vision changes or unusual visual symptoms.
- Crizotinib can interact with medicines that affect CYP3A enzymes and other medications that influence heart rhythm.
- Pregnancy-related precautions are important because crizotinib may cause fetal harm.
- Treatment should be supervised by an oncologist experienced in targeted cancer therapy.
Product Information
- Product Name: Crizotinib 250mg Capsule
- Brand Name: LuciCriz
- Generic Name: Crizotinib
- Strength: 250mg
- Dosage Form: Capsule
- Pack Size: 60 Capsules
- Manufacturer: Lucius Pharmaceuticals (Lao) Co., Ltd.
- Country of Manufacture: Laos
FAQs for Crizotinib 250mg Capsule (LuciCriz) Price in Pakistan
What is Crizotinib 250mg Capsule used for?
Crizotinib is used for selected patients with metastatic non-small cell lung cancer whose tumours test positive for ALK or ROS1 genetic alterations.
What is LuciCriz 250mg?
LuciCriz 250mg is a branded crizotinib capsule manufactured by Lucius Pharmaceuticals (Lao) Co., Ltd.
Is Crizotinib a targeted cancer therapy?
Yes. Crizotinib is a kinase inhibitor that targets proteins such as ALK, ROS1 and MET, which are involved in cancer-cell signalling.
Does Crizotinib require genetic testing?
Yes. Molecular testing is important to identify patients with the specific tumour alterations that may respond to crizotinib.
What is the recommended dose of Crizotinib 250mg?
For adults with ALK-positive or ROS1-positive metastatic NSCLC, the commonly recommended dose is 250mg twice daily. The treating oncologist determines the appropriate regimen.
How many capsules are included in a LuciCriz pack?
The manufacturer’s listed LuciCriz pack contains 60 capsules of 250mg each.
Does Crizotinib require a prescription?
Yes. It is a prescription anticancer medicine that requires molecular testing, oncologist supervision and regular monitoring.
Crizotinib 250mg in Pakistan
Customers searching for Crizotinib 250mg Capsule (LuciCriz) in Pakistan can contact Impo Medic for product information and order-related assistance. For queries about Crizotinib 250mg price in Pakistan, LuciCriz 250mg availability, or imported Crizotinib capsules, product details and supply can be confirmed directly with the team. Prescription requirements apply.

Reviews
There are no reviews yet.